Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience
Abbott Laboratories (NYSE:ABT) ranks among the best medical device stocks to invest in. Benchmark began coverage of Abbott Laboratories (NYSE:ABT) on October 10 with a $145 price target and a Buy ...
Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 ...
Abbott Laboratories (NYSE:ABT) produces a wide range of healthcare products and medical devices, with its business divided into four main areas: established pharmaceuticals, diagnostics, nutrition, ...
ROCKVILLE, Md.--(BUSINESS WIRE)--Abt Global, a mission-driven consulting and research firm working in 50+ countries to improve the quality of people's lives, today announced that it has acquired TSPi, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback